Signalling by extracellular nucleotides in health and disease

Biochim Biophys Acta Mol Cell Res. 2022 May;1869(5):119237. doi: 10.1016/j.bbamcr.2022.119237. Epub 2022 Feb 9.

Abstract

Nucleotides are released from all cells through regulated pathways or as a result of plasma membrane damage or cell death. Outside the cell, nucleotides act as signalling molecules triggering multiple responses via specific plasma membrane receptors of the P2 family. In the nervous system, purinergic signalling has a key function in neurotransmission. Outside the nervous system, purinergic signalling is one of the major modulators of basal tissue homeostasis, while its dysregulation contributes to the pathogenesis of various disease, including inflammation and cancer. Pre-clinical and clinical evidence shows that selective P2 agonists or antagonists are effective treatments for many pathologies, thus highlighting the relevance of extracellular nucleotides and P2 receptors as therapeutic targets.

Keywords: Extracellular nucleotides; G protein-coupled receptors; Ion channels; Neurotransmission; Purinergic signalling; Therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / pathology
  • Cell Membrane / metabolism
  • Humans
  • Lung Diseases / metabolism
  • Lung Diseases / pathology
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Nucleotides / analysis
  • Nucleotides / metabolism*
  • Receptors, Purinergic P2X / metabolism
  • Receptors, Purinergic P2Y / metabolism
  • Signal Transduction*

Substances

  • Nucleotides
  • Receptors, Purinergic P2X
  • Receptors, Purinergic P2Y